Brief: LAVA Therapeutics Q2 basic EPS USD -0.48
Aug 22 (Reuters) - LAVA Therapeutics Q2 net income USD -12.7 million. * Q2 pretax profit USD -12.603 million * Q2 basic EPS USD -0.48 * Q2 gross profit USD 2.751 million * Q2 operating expenses USD -16.296 million * Q2 operating income USD -13.545 million
Recent news on LAVA Therapeutics NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:29 PM
Brief: Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM